arrow
K

Katharine J. Bar

Perelman School of Medicine
H指数:32
被引数:5,456

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV V2 apex broadly neutralizing antibody development

Env-antibody共进化识别B细胞初始为HIV V2顶点广谱中和抗体发展的主要瓶颈

2026-02-130
PRE
Phase 2 Trial of Long-Acting Cabotegravir and VRC07-523LS for Viral Suppression in Adults With Human Immunodeficiency Virus Type 1: ACTG A5357

II期临床试验:长效卡博特韦(Cabotegravir)和VRC07-523LS用于人类免疫缺陷病毒1型成人患者的病毒抑制(ACTG A5357)

2025-08-011
PRE
Assessing the impact of autologous virus neutralizing antibodies on viral rebound time in postnatally SHIV-infected ART-treated infant rhesus macaques
2024-09-010
OA
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication (vol 131, e144486, 2021)
2024-05-011
OAAI
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials ( vol 14 , 8299 , 2023)
2024-03-220
OAAI
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials
2023-12-144
OAAI